Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
about
Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Immunotherapy in Peripheral NeuropathiesIntravenous immunoglobulin in the treatment of neurologic disorders.Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.Early predictive factors of disability in CIDP.Brachial plexus magnetic resonance imaging differentiates between inflammatory neuropathies and does not predict disease course.The role of regulatory T cells in nervous system pathologies.Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Postural tremor and chronic inflammatory demyelinating polyneuropathy.Chronic Inflammatory Demyelinating Polyneuropathy Variant with Creatine-Kinase Elevation and Vanishing Effect of Immunoglobulins.Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDPDADS neuropathy associated with anti-TNF-α therapy.Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.MRI biomarkers of proximal nerve injury in CIDP.CIDP presenting as recurrent severe back pain without weakness or sensory loss.Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP).Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence
P2860
Q35950471-8AD19E70-768A-46D0-B8F9-8BD89C88EC05Q36005389-DCCF3C3E-E08E-49C3-9361-193B43230A2DQ36484418-04A2AF64-AFFE-46B5-A2F8-6A77222A0EEBQ38495457-8788E7B2-BD0A-467A-8A6D-61BC37DEF1BEQ38590743-8B89F1BB-5A94-4394-AA7C-D59EBEADC6E4Q38599369-5A81716B-1430-49B7-B0D9-ACE7D4E48BC7Q38645214-8183A9D4-ADF5-435B-83F5-E72967A180FEQ38775738-44D8FE32-CC33-4D7C-A93D-9320A6C8FD74Q39295050-34099DE2-0ED8-48B3-94AC-865B1B8DE0B6Q39434973-54413D2A-35C5-4E0D-8E2C-F1A4463A452FQ39597507-AF94EA29-A8AA-444C-B775-7572D01C31B6Q41253790-88654E75-2A66-49EB-8B0F-D37854AE1919Q42290388-428CDE63-BA4F-4908-9E15-5A0C3C2113ECQ45979962-F4D112AD-DA64-4C40-9748-FE1A5D3F7120Q48301410-A8DF62F5-E13F-4937-B100-DD2FFAEE5C31Q49626870-70CAA1DB-F05C-41B9-A8E1-9F43BE282D80Q51698475-1AD17E6C-1A29-4C6B-9672-0A0BF2B3CD0EQ53645609-A0260B79-70C4-4EBF-95F5-743CD0FB8691Q57492183-97229B0B-E615-467F-81CD-F71B299EA90A
P2860
Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chronic inflammatory demyelina ...... we are and where we should go.
@en
type
label
Chronic inflammatory demyelina ...... we are and where we should go.
@en
prefLabel
Chronic inflammatory demyelina ...... we are and where we should go.
@en
P2860
P356
P1476
Chronic inflammatory demyelina ...... we are and where we should go
@en
P2093
Eduardo Nobile-Orazio
P2860
P356
10.1111/JNS5.12053
P577
2014-03-01T00:00:00Z